1CINTESIS–Center for Health Technology and Services Research, Medical Research Center, University of Porto, Porto, Portugal

2University of Iowa, Iowa City, IA

3Rutgers New Jersey Medical School, Newark, NJ

4Bar Ilan University and Galilee Medical Center, Nahariya, Israel

5Douglass Hanly Moir Pathology, Sydney, Australia

6Department of Surgical Science University of Torino, Torino, Italy

7The Kirby Institute, UNSW Sydney, Sydney, Australia

8Hospital Lusíadas Porto, Porto, Portugal

9Lower Genital Tract Disease Unit, Centro Hospitalar de São João, Porto, Portugal

10LAP—a Unilabs company, Porto, Portugal

Reprint requests to: Andreia Albuquerque, MD, PhD, CINTESIS–Center for Health Technology and Services Research, Faculty of Medicine of the University of Porto, R. Dr. Plácido da Costa, 4200-450 Porto, Portugal. E-mail: [email protected]

J.B. reports research grants from Merck Sharp & Dohme Corp (MSD), a subsidiary of Merck & Co, Inc (Kenilworth, NJ). I.M.P. received travel funding from Seqiris. P.V.-B. was an investigator for Seegene and received speaker fees from Seegene, Merck, Gedeon-Richter, and Roche. The other authors have declared they have no conflicts of interest.

Institutional review board or ethics committee: not necessary.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (www.jlgtd.com).